IceCure Medical Ltd (ICCM)
NASDAQ: ICCM
· Real-Time Price · USD
0.94
-0.03 (-3.29%)
At close: Jun 16, 2025, 3:59 PM
0.98
3.95%
After-hours: Jun 16, 2025, 07:40 PM EDT
-3.29% (1D)
Bid | 0.94 |
Market Cap | 53.32M |
Revenue (ttm) | 3.28M |
Net Income (ttm) | -15.29M |
EPS (ttm) | -0.28 |
PE Ratio (ttm) | -3.37 |
Forward PE | -5.88 |
Analyst | Buy |
Ask | 1.03 |
Volume | 266,643 |
Avg. Volume (20D) | 264,596 |
Open | 0.99 |
Previous Close | 0.97 |
Day's Range | 0.94 - 1.00 |
52-Week Range | 0.48 - 1.66 |
Beta | 2.59 |
About ICCM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ICCM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ICCM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-15.54%
IceCure Medical shares are trading lower. The comp...
Unlock content with
Pro Subscription
7 months ago
+18.18%
IceCure Medical shares are trading higher after the company announced that a large number of public comments have been posted from key stakeholders ahead of the FDA Medical Device Advisory Committee Panel for marketing authorization of ProSens® cryoablation in early-stage low risk breast cancer.